Olaplex shares plummet after company cuts guidance
Shares of Montecito-based Olaplex dropped more than 50% on Oct. 19 after the hair care products company slashed its revenue guidance for the full 2022 fiscal year fiscal. Olaplex shares closed at $4.24 on Oct. 19, down 56.7% from the previous day’s close. The company released preliminary third quarter earnings on Oct. 18, with executives Read More →
ExxonMobil buys damaged Plains All American oil pipeline
For more than seven years, ExxonMobil has left its oil in the ground off the coast of Santa Barbara County, with no way to transport it since the rupture of Plains All American’s pipeline near Refugio State Beach. Now ExxonMobil will take a shot at moving the oil itself, after purchasing the broken pipeline from Read More →
Merger of U.S. Bank and Union Bank gets final U.S. approval
U.S. Bank’s $8 billion acquisition of Union Bank has the green light from U.S. regulators, a big step forward for a deal that could make U.S. Bank one of the biggest retail banking companies in the tri-county region. The deal received its final U.S. regulatory approvals on Oct. 14, more than a year after it Read More →
SoCalGas compressor project in Ventura to get closer look from regulators
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Housing conference digs into tiny homes, commercial conversions and other solutions
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
A rocky first year on the Nasdaq for Olaplex
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen shares up amid optimism over experimental weight-loss drug
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
